TTrialPathMatch Me to Trials
← Back to trials
RecruitingPrimary Sjogren's Disease

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

Eligible age

18–75 yrs

Accepts

All genders

Locations

16 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease (UPSTREAM SjD)

Sponsor: Vor Biopharma

You may qualify if…

  • ✓ 1. Male or female aged 18 to 75 years of age (both inclusive) at screening
  • ✓ 2. Participants must meet the 2016 American College of Rheumatology (ACR)/EULAR classification criteria for primary Sjogren's Syndrome at the time of screening.
  • ✓ 3. ESSDAI ≥5 at screening (score calculated excluding renal, pulmonary and neurological domains)
  • ✓ 4. Participants are seropositive for antibodies to Sjogren's Syndrome A (SSA)/Anti-Sjogren's Syndrome A (Ro) at the Screening Visit.
  • ✓ Additional inclusion criteria are defined in the protocol

You may not qualify if…

  • ✕ 1. Participants who have a systemic autoimmune disease other than Primary Sjogren's Disease, such as rheumatoid arthritis, systemic lupus erythematosus, or systemic sclerosis, that can better explain the majority of the symptoms (i.e., secondary Sjogren's Disease)
  • ✕ 2. Participants who have another autoimmune disease or inflammatory condition that could interfere with assessment of response of Primary Sjogren's Disease to therapy (e.g., systemic sclerosis, inflammatory bowel disease, gout).
  • ✕ 3. Participants with severe fibromyalgia that could interfere with the assessment of response of Primary Sjogren's Disease to therapy
  • ✕ 4. Active life-threatening or organ-threatening complications of Primary Sjogren's Disease at the time of screening based on investigator evaluation
  • ✕ 5. Significant, uncontrolled medical disease in any organ system not related to Primary Sjogren's Disease (e.g., poorly controlled asthma, cardiovascular disease, accelerated hypertension, major depression, etc.) that in the opinion of the investigator would preclude participant participation.
  • ✕ Additional exclusion criteria are defined in the protocol

Where it's recruiting

Arizona

Chandler · Flagstaff · Glendale · Phoenix …

California

Beverly Hills

Colorado

Denver · Fort Collins · Tampa

Florida

Clearwater · Cooper City · Green Acres · Miami …

Idaho

Boise

Illinois

Chicago · Schaumburg · Willowbrook

Louisiana

Lake Charles

Maryland

Rockville

Michigan

Saint Clair Shores

Missouri

Kansas City

North Carolina

Charlotte · Durham

Source: ClinicalTrials.gov · NCT07404865 · last updated 2026-10-19